Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

被引:35
|
作者
Mamiya, Y [1 ]
Kanazawa, H [1 ]
Kimura, Y [1 ]
Narahara, Y [1 ]
Yamate, Y [1 ]
Nakatsuka, K [1 ]
Sakamoto, C [1 ]
机构
[1] Nippon Med Coll, Dept Internal Med 3, Bunkyo Ku, Tokyo 1138603, Japan
关键词
transjugular intrahepatic portosystemic shunt; complications; hepatic encephalopathy; liver cirrhosis; portal hypertension;
D O I
10.1016/j.hepres.2004.09.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of this prospective study was to investigate the incidence, clinical features and the short- and long-term clinical course of hepatic encephalopathy (HE) after transjugular intrahepatic portosysternic shunt (TIPS) in Japanese patients. Eighty-seven consecutive patients with liver cirrhosis presenting with complications of portal hypertension underwent TIPS. The mean follow-up period after TIPS was 866 days. During the follow-up, HE occurred in 52% of patients throughout the follow-up period. The cumulative incidence of postTIPS HE was 50.5 +/- 5.6% at 1 year (mean +/- S.D.). Most cases (89%) occurring within 7 days were easily controlled by the conventional therapy. Only two patients developed severe chronic HE, which was treated by reducing the shunt diameter. Older age, indication for TIPS (ascites) and higher retention rate of indocyanine green at 15 min were identified as risk factors for post-TIPS HE. During long-term follow-up, the incident of post-TIPS HE decreased among survivals. The cumulative survival rate was similar in patients with or without post-TIPS HE. Our results indicate that post-TIPS HE are a frequent complication, particularly in the early months after TIPS. However., it can be easily managed in the majority of patients. The development of post-TIPS HE is not associated with poor prognosis in TIPS patients. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 50 条
  • [41] Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis:: Clinical, laboratory, psychometric, and electroencephalographic investigations
    Nolte, W
    Wiltfang, J
    Schindler, C
    Münke, H
    Unterberg, K
    Zumhasch, U
    Figulla, HR
    Werner, G
    Hartmann, H
    Ramadori, G
    HEPATOLOGY, 1998, 28 (05) : 1215 - 1225
  • [42] Critical Flicker Frequency as a Marker of Hepatic Encephalopathy in Patients before and after Transjugular Intrahepatic Portosystemic Shunt
    Biecker, Erwin
    Hausdoerfer, Iris
    Gruenhage, Frank
    Strunk, Holger
    Sauerbruch, Tilman
    DIGESTION, 2011, 83 (1-2) : 24 - 31
  • [43] Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision
    Michael W. Rowley
    Myunghan Choi
    Steve Chen
    Kevin Hirsch
    Anil B. Seetharam
    CardioVascular and Interventional Radiology, 2018, 41 : 1765 - 1772
  • [44] Real World Predictors of Hospital Readmission for Hepatic Encephalopathy after Placement of Transjugular Intrahepatic Portosystemic Shunt
    Rowley, Michael
    Ramanathan, Meera
    Choi, Myunghan
    Pedersen, Mark
    Seetharam, Anil B.
    HEPATOLOGY, 2016, 64 : 709A - 710A
  • [45] High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation
    Kloster, Marie-Louise
    Ren, Albert
    Shah, Ketan Y.
    Alqadi, Murad M.
    Bui, James T.
    Lipnik, Andrew J.
    Niemeyer, Matthew M.
    Ray, Charles E.
    Gaba, Ron C.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (11) : 4058 - 4062
  • [46] High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation
    Marie-Louise Kloster
    Albert Ren
    Ketan Y. Shah
    Murad M. Alqadi
    James T. Bui
    Andrew J. Lipnik
    Matthew M. Niemeyer
    Charles E. Ray
    Ron C. Gaba
    Digestive Diseases and Sciences, 2021, 66 : 4058 - 4062
  • [47] Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients
    Yin, Xiaochun
    Zhang, Feng
    Xiao, Jiangqiang
    Wang, Yi
    He, Qibin
    Zhu, Hao
    Leng, Xiafei
    Zou, Xiaoping
    Zhang, Ming
    Zhuge, Yuzheng
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (10) : 1264 - 1269
  • [48] Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision
    Rowley, Michael W.
    Choi, Myunghan
    Chen, Steve
    Hirsch, Kevin
    Seetharam, Anil B.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (11) : 1765 - 1772
  • [49] Etiology of cirrhosis predicts deterioration of "brain reserve" after hepatic encephalopathy or transjugular intrahepatic portosystemic shunt
    Butterworth, Roger F.
    LIVER TRANSPLANTATION, 2015, 21 (09) : 1115 - 1116
  • [50] Hepatic infarct after placement of a transjugular intrahepatic portosystemic shunt (TIPS)
    Shah, S. Mubashir A.
    Regev, Arie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S154 - S155